Drug Profile
Doxorubicin liposomal - Jina Pharmaceuticals
Latest Information Update: 24 Jan 2019
Price :
$50
*
At a glance
- Originator Jina Pharmaceuticals
- Class Anthracyclines; Antineoplastics; Antivirals; Cytostatic antibiotics; Doxorubicins; Hepatoprotectants; Small molecules
- Mechanism of Action DNA intercalators; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cancer
Most Recent Events
- 24 Jan 2019 Launched for Cancer in India, prior January 2019 (IV)
- 01 Sep 2015 Registered for Cancer in India (IV) before September 2015